Immunogenicity Study of Wockhardt's Insulin Lispro/Lispro Mix Basal Bolus Regimen in Type 1 Diabetics
NCT01398670
·
clinicaltrials.gov ↗
PHASE3
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class
Stopped
Study was not initiated
Conditions
Type I Diabetes
Interventions
BIOLOGICAL:
Insulin Lispro
BIOLOGICAL:
Insulin Lispro
Sponsor
Wockhardt